Under the leadership of CEO and dean Dr. Grossman, NYU Langone Health is setting new standards of excellence in patient care, scientific research and medical education while maintaining strong financial health and strategic growth. Dr. Grossman’s data-driven approach to quality management has led to consistent, life-saving patient outcomes, using a proprietary dashboard tracking over 800 metrics, including health equity measures. Under his direction, NYU Langone was named the No. 1 comprehensive academic medical center for quality care in the U.S. for three years in a row by Vizient Inc., earned top 20 rankings in 13 clinical specialties by U.S. News & World Report, and received a 5-star rating from CMS and consecutive “A” grades from the Leapfrog Group. He has also overseen significant ambulatory expansion, bringing leading-edge care to patients across New York and Florida, growing NYU Langone’s footprint to over 320 locations. Dr. Grossman was the driving force behind tuition-free medical education, launching the NYU Grossman Long Island School of Medicine and ensuring full-tuition scholarships in perpetuity to train much-needed primary care physicians. Since he took the helm, NYU Langone’s revenue has grown from $2 billion in 2007 to over $14.2 billion in 2024, with an upgrade to “A1” by Moody’s and more than $5 billion in philanthropic giving. A globally recognized leader in neuroradiology, he was elected to the American Academy of Arts and Sciences in 2022 and is a fellow of the International Society for Magnetic Resonance in Medicine.
